Zentalis Pharmaceuticals, Inc. listed its shares on the Nasdaq stock exchange on July 24, 2026.
3 reports, 2 independent
Updated Mon 00:00
Still developing
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Zentalis Pharmaceuticals, Inc. listed its shares on the Nasdaq stock exchange on July 24, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.New analyst coverage from Leerink and Mizuho on Zentalis Pharmaceuticals.1 source
Zentalis Pharmaceuticals listed on Nasdaq.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Qfin Holdings, Inc. listed its shares on the electronic stock exchange on October 5, 2026.
- Harte Hanks was listed on the Nasdaq stock exchange on August 14, 2026.
- Aaron was listed on the Nasdaq stock exchange today.
- Brilliant Earth Group, Inc. was listed on the Nasdaq stock exchange on August 3, 2026.
- Koss Corporation was listed on the stock exchange on August 1, 2026.
Coverage
Newest first; wire copies grouped- tickerreport.com
- dailypolitical.comBrokerages Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Price Target at $6.14